Latest News and Press Releases

· Les activités françaises seront concentrées sur le site de Lyon · Consolidation de la R&D à Vienne Saint-Herblain (France), le 26 novembre 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA)...

French operations to be concentrated at its Lyon site Final consolidation of R&D in Vienna  Saint-Herblain (France), November 26, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris:...

Antibody levels remained well above baseline across all six serotypes and age groups sixth month after third yearly booster doseNo safety concerns observed in any age group by an independent Data...

Les taux d'anticorps sont restés supérieurs à leur niveau initial pour les six sérotypes et dans toutes les tranches d’âge six mois après la dernière injection des trois doses de rappel  Aucun...

Ottawa, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The global GMP drug substance market size was valued at USD 2.55 billion in 2024 and is predicted to hit around USD 4.64 billion by 2034, rising at a 6.14%...

Ottawa, Nov. 20, 2025 (GLOBE NEWSWIRE) -- The global travel vaccination service market size was valued at USD 4.69 billion in 2024 and is predicted to hit around USD 11.99 billion by 2034, rising at...

Gesamtumsatz von 127,0 Millionen Euro gegenüber 116,6 Millionen Euro in den ersten neun Monaten des Jahres 2024Liquide Mittel in Höhe von 143,5 Millionen Euro per Ende September 2025Finanzielle...

Total revenues of €127.0 million compared to €116.6 million in the first nine months of 2024Cash and cash equivalents of €143.5 million at end of September 2025Financial flexibility enhanced with...

Chiffre d’affaires de 127,0 millions d’euros contre 116,6 millions d’euros sur les neuf premiers mois de 2024Trésorerie de 143,5 millions d’euros à fin septembre 2025Flexibilité financière accrue...

VALNEVA Declaration of shares and voting rights October 31, 2025__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6...